Document 0246
 DOCN  M9650246
 TI    Long-term survivors of HIV-1 infection.
 DT    9605
 AU    Klein MR; Miedema F; Dept of Clinical Viro-immunology, Central
       Laboratory of The; Netherlands, Red Cross Blood Transfusion Service,
       Amsterdam, The; Netherlands.
 SO    Trends Microbiol. 1995 Oct;3(10):386-91. Unique Identifier : AIDSLINE
       MED/96124456
 AB    The clinical course and outcome of HIV-1 infection are highly variable.
       A full spectrum of pathology has been observed, from rapid progression
       to AIDS within months of HIV-1 seroconversion, to asymptomatic survival
       for more than a decade. This phenomenon probably reflects the
       multiphasic and multifactorial nature of the virus-host interactions.
       Obviously, interest in the extremes now recognized in HIV-1 disease
       progression is growing, with the hope that mechanisms of protection may
       be found.
 DE    Disease Progression  Forecasting  Human  HIV
       Infections/EPIDEMIOLOGY/*PHYSIOPATHOLOGY  *HIV-1/PATHOGENICITY
       Immunity, Natural  Nomenclature  Support, Non-U.S. Gov't  *Survivors
       JOURNAL ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).